Leonard L. Mazur - 10 Oct 2023 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Alexander M. Donaldson, by power of attorney
Issuer symbol: CTXR
Transactions as of: 10 Oct 2023
Net transactions value: $0
Form type: 4
Filing time: 12 Oct 2023, 16:15:21 UTC
Previous filing: 09 Nov 2023
Next filing: 05 Apr 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CTXR	Common Stock						10,255,343	10 Oct 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTXR	Option to Purchase Common Stock	Award	$0	+550,000		$0.000000	550,000	10 Oct 2023	Common Stock	550,000	$0.7000	Direct	F10
holding	CTXR	Options to Purchase Common Stock						40,000	10 Oct 2023	Common Stock	40,000	$3.45	Direct	F1
holding	CTXR	Options to Purchase Common Stock						220,000	10 Oct 2023	Common Stock	220,000	$6.75	Direct	F2
holding	CTXR	Warrant to Purchase Common Stock						3,137,255	10 Oct 2023	Common Stock	3,137,255	$1.15	Direct	F3
holding	CTXR	Options to Purchase Common Stock						150,000	10 Oct 2023	Common Stock	150,000	$1.62	Direct	F4
holding	CTXR	Warrant to Purchase Common Stock						1,165,048	10 Oct 2023	Common Stock	1,165,048	$1.42	Direct	F3
holding	CTXR	Warrant to Purchase Common Stock						2,234,700	10 Oct 2023	Common Stock	2,234,700	$0.7700	Direct	F3
holding	CTXR	Options to Purchase Common Stock						175,000	10 Oct 2023	Common Stock	175,000	$0.6700	Direct	F5
holding	CTXR	Options to Purchase Common Stock						200,000	10 Oct 2023	Common Stock	200,000	$1.01	Direct	F6
holding	CTXR	Options to Purchase Common Stock						300,000	10 Oct 2023	Common Stock	300,000	$2.00	Direct	F7
holding	CTXR	Option to Purchase Common Stock						650,000	10 Oct 2023	Common Stock	650,000	$2.04	Direct	F8
holding	CTXR	Option to Purchase Common Stock						550,000	10 Oct 2023	Common Stock	550,000	$1.25	Direct	F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vested in full on September 13, 2020.
F2	The options vested in full on September 12, 2017
F3	The warrant is fully vested and exercisable immediately.
F4	The options vested in full on September 4, 2021.
F5	The options vested in full on October 8, 2022.
F6	The options vested in full on October 6, 2023.
F7	The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F8	The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F9	The options were granted on October 4, 2022. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.
F10	The options were granted on October 10, 2023. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.